CRISTAL PAYNE: Open Payments
NPI 1376099960 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$273 in 14 payments from 7 companies in 2025. Trend: 2023 $13 · 2024 $128 · 2025 $273
Food & beverage: $273
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 4 | $93 |
| Lilly USA, LLC | 4 | $70 |
| ABBVIE INC. | 2 | $30 |
| Sumitomo Pharma America, Inc. | 1 | $24 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
| Dexcom, Inc. | 1 | $14 |
Products named: FREESTYLE LIBRE 3, JARDIANCE, VRAYLAR, GEMTESA, XIFAXAN, ZEPBOUND, GVOKE HYPOPEN, MOUNJARO.
Industry payments across TN — which companies pay providers there.
